IL185723A0 - Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same - Google Patents

Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same

Info

Publication number
IL185723A0
IL185723A0 IL185723A IL18572307A IL185723A0 IL 185723 A0 IL185723 A0 IL 185723A0 IL 185723 A IL185723 A IL 185723A IL 18572307 A IL18572307 A IL 18572307A IL 185723 A0 IL185723 A0 IL 185723A0
Authority
IL
Israel
Prior art keywords
liothyronine
making
methods
same
pharmaceutical compositions
Prior art date
Application number
IL185723A
Other languages
English (en)
Original Assignee
King Pharmaceuticals Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Res & Dev filed Critical King Pharmaceuticals Res & Dev
Publication of IL185723A0 publication Critical patent/IL185723A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL185723A 2005-03-31 2007-09-04 Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same IL185723A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66662105P 2005-03-31 2005-03-31
PCT/US2006/012272 WO2006105482A2 (en) 2005-03-31 2006-03-31 Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same

Publications (1)

Publication Number Publication Date
IL185723A0 true IL185723A0 (en) 2008-01-06

Family

ID=37054215

Family Applications (1)

Application Number Title Priority Date Filing Date
IL185723A IL185723A0 (en) 2005-03-31 2007-09-04 Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same

Country Status (11)

Country Link
US (1) US20060246133A1 (enExample)
EP (1) EP1863446A2 (enExample)
JP (1) JP2008534621A (enExample)
KR (1) KR20070119714A (enExample)
CN (1) CN101175477A (enExample)
AU (1) AU2006230557A1 (enExample)
BR (1) BRPI0609779A2 (enExample)
CA (1) CA2603313A1 (enExample)
IL (1) IL185723A0 (enExample)
MX (1) MX2007011826A (enExample)
WO (1) WO2006105482A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525461D0 (en) 2005-12-15 2006-01-25 Archimedes Dev Ltd Pharmaceutical compositions
WO2008057464A2 (en) * 2006-11-01 2008-05-15 King Pharmaceuticals Research And Development, Inc. Compositions and methods for improving the bioavailability of liothyronine
ATE553753T1 (de) * 2007-02-16 2012-05-15 Suisse Electronique Microtech Überprüfungsverfahren
ITMI20112066A1 (it) * 2011-11-14 2013-05-15 Altergon Sa Preparazione farmaceutica orale monodose di ormoni tiroidei t3 e t4
KR20180132955A (ko) * 2016-05-03 2018-12-12 스펙트릭스 테라퓨틱스, 엘엘씨 갑상샘 호르몬 또는 이의 유사체를 제공하는 조성물 및 방법
US10695309B2 (en) * 2017-03-31 2020-06-30 Western New England University Sustained-release liothyronine formulations, method of preparation and method of use thereof
US11964048B2 (en) * 2020-12-18 2024-04-23 Amneal Complex Products Research Llc Sustained release compositions comprising liothyronine
EP4511009A1 (en) * 2022-04-22 2025-02-26 Prolevi Bio AB Compositions for modified release of active ingredients
CN115645361B (zh) * 2022-09-30 2023-11-21 天津市眼科医院 一种用于加强角膜生物力学性质的眼用制剂及t3的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200193A (en) * 1987-04-22 1993-04-06 Mcneilab, Inc. Pharmaceutical sustained release matrix and process
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
EP0550108B1 (en) * 1991-12-30 1998-03-18 Akzo Nobel N.V. Sustained release thyroactive composition
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6555581B1 (en) * 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods

Also Published As

Publication number Publication date
US20060246133A1 (en) 2006-11-02
AU2006230557A1 (en) 2006-10-05
BRPI0609779A2 (pt) 2011-10-18
KR20070119714A (ko) 2007-12-20
JP2008534621A (ja) 2008-08-28
CA2603313A1 (en) 2006-10-05
CN101175477A (zh) 2008-05-07
WO2006105482A2 (en) 2006-10-05
WO2006105482A3 (en) 2006-12-07
MX2007011826A (es) 2007-11-22
EP1863446A2 (en) 2007-12-12

Similar Documents

Publication Publication Date Title
IL189795A0 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
IL191072A0 (en) Therapeutic compositions and methods
ZA200808431B (en) Fungicidal compositions and methods of using the same
EP2136638A4 (en) MODIFIED RELEASE FORMULATIONS OF (6R) -4,5,6,7-TETRAHYDRO-N6-PROPYL-2,6-BENZOTHIAZOLE DIAMINE AND METHODS OF USE THEREOF
IL188941A0 (en) Pyrazinolyguanidine derivatives and pharmaceutical compositions containing the same
IL186738A0 (en) Pyrizole derivatives and pharmaceutical compositions containing the same
IL183919A0 (en) Triazolophthalazine derivatives and pharmaceutical compositions containing the same
IL184735A0 (en) Pharmaceutical formulations and methods of use
ZA200710858B (en) Diclofenac formulations and methods of use
EP1932882A4 (en) HARDENING COMPOSITION AND OPTICAL ELEMENT THEREFOR
IL186127A (en) Subcutaneous preparations for the treatment of depression and methods for their preparation
IL184834A0 (en) Compositions and methods for the manufacture thereof
ZA200800128B (en) Compositions and methods for altering the color of teeth
ZA200803987B (en) Novel process and formulations
IL190239A0 (en) Pharmaceutical gallium compositions and methods
IL185723A0 (en) Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same
IL186325A0 (en) Tizanidine compositions and methods of treatment using the compositions
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
IL184996A0 (en) Dihydroimidazothiazole derivatives and pharmaceutical compositions containing the same
ZA200805711B (en) Solid biocidal compositions and methods of using the same
IL187405A0 (en) Methods and compositions for the treatment of pain
IL188011A0 (en) Spiro-benzimidazole derivatives and pharmaceutical compositions containing the same
IL186337A0 (en) Stannsoporfin compositions and administration
EP1834624A4 (en) MEDICAL COMPOSITION AND MANUFACTURING METHOD THEREFOR
EP1912630A4 (en) COMPOSITIONS AND METHODS FOR REDUCING POSTOPERATIVE PAIN